Grateful thanks are given to the following people who have generously contributed with their time as reviewers for the first four papers in this issue and also appreciation to Dr. Syed Ghulam Sarwar Shah, Brunei University, Uxbridge, Middlesex, UK and Dr. Khalil Khoumbati, Institute of Information and Communication Technology, University of Sindh, Jamshoro, Sindh, Pakistan, for their invaluable help.
展开▼
机译：结合人CD20的人单克隆抗体，该抗体能够在存在补体的情况下诱导表达CD2的细胞的补体依赖性细胞毒性，并且包含根据EP1558648B1的权利要求1的轻链和重链CDR区， i），（ii）（a）和（iii）（SEQ ID Nos.16、17、18、13、14和15），特别是包含轻链和重链可变区序列的抗体根据EP1558648B1的权利要求4（SEQ ID Nos.4和2），特别是ofatumumab
